ClinicalThought
View More
In this case-based commentary, we review pharmacist-driven strategies at the patient, provider, and healthcare system levels for overcoming health disparities among patients who receive immune checkpoint inhibitor–based therapy.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.